VERO Biotech
PrivateLast Round
Debt
Feb 7, 2024
Total Funding Raised
$230.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
VERO Biotech operates in Healthcare & Life Sciences and is based in Atlanta, Georgia. Its latest recorded funding round was a Debt round in February 2024.
VERO Biotech is a biotechnology company that designs, develops, and commercializes inhaled nitric oxide delivery systems for the treatment of pulmonary and cardiac diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VERO Biotech Comparables
Compare VERO Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beyond Air | 88% | |
| Keenova Therapeutics plc | 85% | |
| International Biomedical, Ltd. | 82% |
For institutional investors. Book with your work email.
VERO Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Feb 7, 2024 | ||||
| VC Round | Jan 11, 2023 | ||||
| Series E | Dec 15, 2021 | ||||
| Debt | Jan 12, 2021 | ||||
| Grant | Aug 15, 2011 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
VERO Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Runway Growth Capital | Debt |
| National Institute of Allergy and Infectious Diseases | Grant |
| Monroe Capital | Debt |
| U.S. Department of Health and Human Services | Grant |
| Petrichor Healthcare Capital Management | VC Round |
| Horizon Technology Finance Corporation | Debt |
| MVM Life Science Partners LLP | Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 35% MoM.
- Apr 16, 2026
Monthly visitors increased 48% MoM, reaching 2.7K.
For institutional investors. Book with your work email.
VERO Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VERO Biotech's valuation, stock price, and market status.
Is VERO Biotech a public or private company?
VERO Biotech is a private company.
What is the current stock price of VERO Biotech?
VERO Biotech is a private company, so its shares have no public market price. Caplight tracks VERO Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VERO Biotech worth (valuation)?
Valuation information for VERO Biotech is not publicly available.
Can I buy VERO Biotech stock?
VERO Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VERO Biotech's last funding round?
VERO Biotech's most recent funding round was Debt on February 7, 2024.
Who are the main investors in VERO Biotech?
Key investors in VERO Biotech include Petrichor Healthcare Capital Management, MVM Life Science Partners LLP.
Will VERO Biotech IPO soon?
No public IPO plans have been announced for VERO Biotech.
How can I track VERO Biotech secondary market activity?
Caplight tracks bids, offers, and trades in VERO Biotech's shares on secondary markets.